BioAge Labs (BIOA) Total Current Liabilities (2023 - 2026)

BioAge Labs (BIOA) has 4 years of Total Current Liabilities data on file, last reported at $15.8 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities fell 33.33% year-over-year to $15.8 million; the trailing twelve-month figure through Mar 2026 stood at $15.8 million (down 33.33% YoY), and the FY2025 full-year result was $20.1 million, down 27.5% from the prior year.
• Total Current Liabilities retreated to $15.8 million in Q1 2026, from $20.1 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $58.2 million in Q4 2023 to a low of $15.8 million in Q1 2026.
• A 4-year average of $26.5 million and a median of $23.3 million in 2025 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities tumbled 52.25% in 2024 and increased 28.37% in 2025, its largest moves.
• Tracing BIOA's Total Current Liabilities over 4 years: stood at $58.2 million in 2023, then plunged by 52.25% to $27.8 million in 2024, then retreated by 27.5% to $20.1 million in 2025, then decreased by 21.41% to $15.8 million in 2026.
• Business Quant data shows BIOA's Total Current Liabilities at $15.8 million in Q1 2026, $20.1 million in Q4 2025, and $24.5 million in Q3 2025.